Alternatives to growth hormone stimulation testing in children

被引:45
作者
Badaru, A [1 ]
Wilson, DM [1 ]
机构
[1] Stanford Univ, Med Ctr, Div Pediat Endocrinol & Diabet, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.tem.2004.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite more than 40 years of pediatric growth hormone (GH) replacement, we are still limited in our ability to make a definitive diagnosis of GH deficiency (GHD) in children. Historically, GH stimulation tests (GHSTs) have been used to discriminate between GHD and idiopathic short stature. Over the years, increases in the peak diagnostic GH cutoffs and the proliferation of GH assays have fundamentally changed the nature of the GHST. In our opinion, today's GHSTs lack reproducibility and accuracy, are expensive, and can be dangerous. Moreover, newer diagnostic tools, such as high-resolution neuroimaging, measurements of serum insulin-like growth factor 1 and insulin-like growth factor-binding protein 3, and an increasing number of genetic tests, have emerged. We believe that it is no longer appropriate to use GHSTs to diagnose childhood GHD. Instead, diagnosis should be based on a combination of auxological, biochemical, neuroradiological and genetic considerations. Here, we examine the alternatives to the GHST that are currently available and literature that supports their use. We believe that these alternative methods should replace the GHST.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 74 条
[1]   DIAGNOSTIC MARKERS OF PERMANENT IDIOPATHIC GROWTH-HORMONE DEFICIENCY [J].
ADAN, L ;
SOUBERBIELLE, JC ;
BRAUNER, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :353-358
[2]   MAGNETIC-RESONANCE-IMAGING IN THE DIAGNOSIS OF GROWTH-HORMONE DEFICIENCY [J].
ARGYROPOULOU, M ;
PERIGNON, F ;
BRAUNER, R ;
BRUNELLE, F .
JOURNAL OF PEDIATRICS, 1992, 120 (06) :886-891
[3]   Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study [J].
Backeljauw, PF ;
Underwood, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1504-1510
[4]  
Baumann Gerhard, 2002, Am J Pharmacogenomics, V2, P93, DOI 10.2165/00129785-200202020-00003
[5]  
BLUM WF, 1993, J CLIN ENDOCR METAB, V76, P1610, DOI 10.1210/jc.76.6.1610
[6]  
Brickman JM, 2001, DEVELOPMENT, V128, P5189
[7]  
Bright GM, 1999, PEDIATRICS, V104, P1028
[8]   VALUE AND LIMITS OF PHARMACOLOGICAL AND PHYSIOLOGICAL TESTS TO DIAGNOSE GROWTH-HORMONE (GH) DEFICIENCY AND PREDICT THERAPY RESPONSE - FIRST AND 2ND RETESTING DURING REPLACEMENT THERAPY OF PATIENTS DEFINED AS GH DEFICIENT [J].
CACCIARI, E ;
TASSONI, P ;
CICOGNANI, A ;
PIRAZZOLI, P ;
SALARDI, S ;
BALSAMO, A ;
CASSIO, A ;
ZUCCHINI, S ;
COLLI, C ;
TASSINARI, D ;
TANI, G ;
GUALANDI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1663-1669
[9]   Final height of patients treated for isolated GH deficiency: Examination of 83 patients [J].
Cacciari, E ;
Cicognani, A ;
Pirazzoli, P ;
Zucchini, S ;
Salardi, S ;
Balsamo, A ;
Cassio, A ;
Pasini, A ;
Carla, G ;
Tassinari, D ;
Gualandi, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (01) :53-60
[10]   Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: A population register-based study [J].
Carel, JC ;
Tresca, JP ;
Letrait, M ;
Chaussain, JL ;
Lebouc, Y ;
Job, JC ;
Coste, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2117-2121